Skip to main content

Washington Capitals Roman Hamrlik chats with Montreal Canadiens Travis Moen during an informal practice

Paul Chiasson/The Canadian Press

The Rangers are adding veteran defenceman Roman Hamrlik to the roster while they wait to find out the severity of Marc Staal's eye injury.

New York claimed the 38-year-old Hamrlik off waivers from the Washington Capitals on Wednesday, one day after Staal was struck in the eye by a deflected puck in the third period of the Rangers' 4-2 win over Philadelphia.

Staal, who wasn't wearing a visor, writhed on the ice in pain before being helped to the dressing room. There was no update to his condition Tuesday night or Wednesday morning.

Story continues below advertisement

Hamrlik, the active leader with 1,383 NHL games played, was waived by the Capitals on Tuesday after playing in only four games this season. He is in the final season of a two-year, $7 million contract.

Hamrlik played in Washington's first three games this season before being scratched for seven straight games. He returned to the lineup Feb. 7 at Pittsburgh, but then sat out nine more games before being waived.

After being chosen No. 1 overall in the 1992 NHL draft, Hamrlik has 155 goals and 483 assists with Tampa Bay, Edmonton, the New York Islanders, Calgary, Montreal and Washington. He has one assist this season.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies